Authors: Fevig, JM Pinto, DJ Han, Q Quan, ML Pruitt, JR Jacobson, IC Galemmo, RA Wang, SA Orwat, MJ Bostrom, LL Knabb, RM Wong, PC Lam, PYS Wexler, RR

Citation: Jm. Fevig et al., Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core, BIOORG MED, 11(5), 2001, pp. 641-645

Authors: Pinto, DJP Orwat, MJ Wang, SG Fevig, JM Quan, ML Amparo, E Cacciola, J Rossi, KA Alexander, RS Smallwood, AM Luettgen, JM Liang, L Aungst, BJ Wright, MR Knabb, RM Wong, PC Wexler, RR Lam, PYS

Citation: Djp. Pinto et al., Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2 '- (methylsulfonyl)-[1,1 '-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa, J MED CHEM, 44(4), 2001, pp. 566-578

Authors: Wong, PC Crain, EJ Knabb, RM Meade, RP Quan, ML Watson, CA Wexler, RR Wright, MR Slee, AM

Citation: Pc. Wong et al., Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis, J PHARM EXP, 295(1), 2000, pp. 212-218

Authors: Wong, PC Quan, ML Crain, EJ Watson, CA Wexler, RR Knabb, RM

Citation: Pc. Wong et al., Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics, J PHARM EXP, 292(1), 2000, pp. 351-357

Authors: Quan, ML Liauw, AY Ellis, CD Pruitt, JR Carini, DJ Bostrom, LL Huang, PP Harrison, K Knabb, RM Thoolen, MJ Wong, PC Wexler, RR

Citation: Ml. Quan et al., Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1, J MED CHEM, 42(15), 1999, pp. 2752-2759

Authors: Quan, ML Ellis, CD Liauw, AY Alexander, RS Knabb, RM Lam, G Wright, MR Wong, PC Wexler, RR

Citation: Ml. Quan et al., Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 2, J MED CHEM, 42(15), 1999, pp. 2760-2773